Trastuzumab Ujvira 100 mg injection

100mg Injection , Vial

4.5 (154)

₹13,000

Trastuzumab Ujvira 100mg Injection is a targeted anticancer medicine used to treat HER2-positive breast cancer that has spread or returned after previous treatment. It combines trastuzumab with a chemotherapy agent to selectively target and destroy HER2-positive cancer cells while minimizing damage to healthy cells. The infusion is administered by a healthcare professional and may be used alone or with other cancer therapies. Follow your doctor’s prescribed treatment plan to achieve the best possible outcomes.

Description

Introduction Of The Trastuzumab Ujvira 100mg Injection:

Ujvira 100mg Injection is a specialised injection used to treat certain types of breast and stomach cancers that produce too much of a protein called HER2. By targeting these specific cancer cells, it helps slow down or stop their growth. This medicine is a key part of targeted cancer therapy prescribed by oncology specialists.

Ujvira 100mg Injection is given as an injection or infusion, typically once every week or every three weeks, depending on your treatment plan. Consistency is vital, so keeping all your scheduled appointments is highly recommended. To support your body during treatment, maintaining a balanced diet, staying well-hydrated, and getting plenty of rest can help manage physical demands.

Some people experience mild side effects like chills, fever, or nausea, particularly during or after the first few sessions. However, you must seek immediate medical help if you experience serious symptoms such as shortness of breath, swelling in your legs, or a rapid heartbeat, as these can point to heart or lung complications.

Before starting Ujvira 100mg Injection, inform your doctor if you have a history of heart disease, high blood pressure, or lung disorders. Do not take this medicine if you have had a severe allergic reaction to it or its ingredients in the past. Pregnant women should also avoid this medicine as it can cause harm to an unborn baby.

Active Ingredient/Salt:

  • Trastuzumab Emtansine

Uses of Ujvira 100mg Injection:

Ujvira 100mg Injection is used to treat certain types of breast and stomach cancers that produce too much HER2. The detailed uses of Ujvira 100 mg Injection are as follows:

  • HER2-positive breast cancer: Ujvira 100 mg Injection helps by targeting and blocking the HER2 receptors on cancer cells, which slows down tumor growth and reduces the risk of the cancer returning after surgery or chemotherapy.
  • HER2-positive metastatic stomach (gastric) cancer: Ujvira 100 mg Injection works in combination with chemotherapy to slow the progression of advanced stomach or gastroesophageal junction cancers that overexpress the HER2 protein.

Benefits of Ujvira 100mg Injection:

Ujvira 100mg Injection offers significant clinical benefits for individuals facing specific types of aggressive cancers. By focusing directly on cancer cells rather than all rapidly dividing cells, it helps limit damage to healthy tissues, resulting in a more targeted approach to cancer care. Key benefits include:

  • Reduced risk of cancer recurrence: When used after surgery for early-stage breast cancer, it significantly lowers the chances of the cancer coming back.
  • Extended survival times: In advanced or metastatic cases of breast and stomach cancer, it helps control tumour growth, which can help extend life and improve comfort.
  • Synergy with chemotherapy: It enhances the effectiveness of standard chemotherapy drugs, making the overall treatment regimen more successful at shrinking tumours.

Mode Of Action For Trastuzumab Ujvira 100mg Injection:

Trastuzumab emtansine’s  includes attaching to the HER2 protein on cancer cells’ surfaces, inhibiting its signalling pathways, and inducing the immune system to destroy the cancer cells. The chemotherapeutic drug DM1 is released from T-DM1 once it has entered the cell, killing the cancer cell.

Contact Us

Info Table
Brand Ujvira 100mg
Form Injection
Composition TRASTUZUMAB-100MG
Manufacturer/Marketer ZYDUS HEALTHCARE LTD
Consume Type Parenteral
Storage Store at 2°C to 8°C
Dosage 100mg
Pack Size 1 Vial
Country of Origin Made in India
Vendor Info
Benefits
Reviews

Description

Introduction Of The Trastuzumab Ujvira 100mg Injection:

Ujvira 100mg Injection is a specialised injection used to treat certain types of breast and stomach cancers that produce too much of a protein called HER2. By targeting these specific cancer cells, it helps slow down or stop their growth. This medicine is a key part of targeted cancer therapy prescribed by oncology specialists.

Ujvira 100mg Injection is given as an injection or infusion, typically once every week or every three weeks, depending on your treatment plan. Consistency is vital, so keeping all your scheduled appointments is highly recommended. To support your body during treatment, maintaining a balanced diet, staying well-hydrated, and getting plenty of rest can help manage physical demands.

Some people experience mild side effects like chills, fever, or nausea, particularly during or after the first few sessions. However, you must seek immediate medical help if you experience serious symptoms such as shortness of breath, swelling in your legs, or a rapid heartbeat, as these can point to heart or lung complications.

Before starting Ujvira 100mg Injection, inform your doctor if you have a history of heart disease, high blood pressure, or lung disorders. Do not take this medicine if you have had a severe allergic reaction to it or its ingredients in the past. Pregnant women should also avoid this medicine as it can cause harm to an unborn baby.

Active Ingredient/Salt:

  • Trastuzumab Emtansine

Uses of Ujvira 100mg Injection:

Ujvira 100mg Injection is used to treat certain types of breast and stomach cancers that produce too much HER2. The detailed uses of Ujvira 100 mg Injection are as follows:

  • HER2-positive breast cancer: Ujvira 100 mg Injection helps by targeting and blocking the HER2 receptors on cancer cells, which slows down tumor growth and reduces the risk of the cancer returning after surgery or chemotherapy.
  • HER2-positive metastatic stomach (gastric) cancer: Ujvira 100 mg Injection works in combination with chemotherapy to slow the progression of advanced stomach or gastroesophageal junction cancers that overexpress the HER2 protein.

Benefits of Ujvira 100mg Injection:

Ujvira 100mg Injection offers significant clinical benefits for individuals facing specific types of aggressive cancers. By focusing directly on cancer cells rather than all rapidly dividing cells, it helps limit damage to healthy tissues, resulting in a more targeted approach to cancer care. Key benefits include:

  • Reduced risk of cancer recurrence: When used after surgery for early-stage breast cancer, it significantly lowers the chances of the cancer coming back.
  • Extended survival times: In advanced or metastatic cases of breast and stomach cancer, it helps control tumour growth, which can help extend life and improve comfort.
  • Synergy with chemotherapy: It enhances the effectiveness of standard chemotherapy drugs, making the overall treatment regimen more successful at shrinking tumours.

Mode Of Action For Trastuzumab Ujvira 100mg Injection:

Trastuzumab emtansine’s  includes attaching to the HER2 protein on cancer cells’ surfaces, inhibiting its signalling pathways, and inducing the immune system to destroy the cancer cells. The chemotherapeutic drug DM1 is released from T-DM1 once it has entered the cell, killing the cancer cell.

Contact Us

Reviews

There are no reviews yet.

Be the first to review “Trastuzumab Ujvira 100 mg injection”

Your email address will not be published. Required fields are marked *

Frequently Asked Questions

From sourcing to delivery, we ensure reliability at every step. Our operations follow strict quality and regulatory standards.

What is Trastuzumab Ujvira 100mg Injection used for?
It is used to treat HER2-positive breast cancer that has spread to other parts of the body or returned after previous treatment.
It works by blocking a protein called HER2 that signals cancer cells to grow, helping slow or stop the growth of HER2-positive breast and stomach cancers. See Drugs.com for more.
Yes, it may be used alone or combined with chemotherapy, radiation therapy, or hormonal therapy depending on the treatment plan.
It contains Trastuzumab 100mg, manufactured by Zydus Ingenia, with a shelf life of 2 years.
It improves progression-free survival, overall survival, and quality of life, and is generally well tolerated with a reduced risk of side effects.
Yes, it must be administered by a healthcare professional and used strictly under medical supervision.

Related products